WAKE FOREST UNIVERSITY HEALTH SCIENCES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Testing Ramipril to Prevent Memory Loss in People With Glioblastoma

Phase 2

Completed

Conditions: Cognitive Decline
Glioblastoma
Radiotherapy; Complications
Chemoradiation

Interventions: Drug: Ramipril

First Posted Date: 2018-03-23

Last Posted Date: 2025-03-26

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 75

Registration Number: NCT03475186

Locations: 🇺🇸
John H Stroger Jr Hospital of Cook County, Chicago, Illinois, United States
🇺🇸
Swedish Medical Center-Ballard Campus, Seattle, Washington, United States
🇺🇸
Swedish Medical Center-Cherry Hill, Seattle, Washington, United States

and more 417 locations

Evaluating the Efficacy of Platelet-rich Plasma Therapy in the Treatment of Androgenic Alopecia

Early Phase 1

Not yet recruiting

Conditions: Androgenic Alopecia

Interventions: Biological: Platelet-rich Plasma Right Side
Biological: Platelet-rich Plasma Left Side

First Posted Date: 2018-03-22

Last Posted Date: 2025-03-24

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 16

Registration Number: NCT03474718

Locations: 🇺🇸
Wake Forest University Baptist Health, Winston-Salem, North Carolina, United States

Brain Energy for Amyloid Transformation in Alzheimer's Disease Study

Not Applicable

Recruiting

Conditions: Alzheimer Disease
Mild Cognitive Impairment

Interventions: Other: low fat/high carbohydrate diet
Other: low carbohydrate/high fat diet

First Posted Date: 2018-03-21

Last Posted Date: 2025-05-01

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 120

Registration Number: NCT03472664

Locations: 🇺🇸
Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States

Multisensory Integration and Pain Perception

Not Applicable

Withdrawn

Conditions: Regulation, Self
Pain

Interventions: Behavioral: Positive reappraisal
Behavioral: Mindfulness meditation

First Posted Date: 2018-03-20

Last Posted Date: 2019-06-05

Lead Sponsor: Wake Forest University Health Sciences

Registration Number: NCT03471689

Locations: 🇺🇸
Wake Forest University, Winston-Salem, North Carolina, United States

Anxiety and Depression in Epilepsy: A Treatment Study

Phase 4

Completed

Conditions: Anxiety
Depression
Epilepsy

Interventions: Drug: Escitalopram 10mg
Other: Referral to Psychiatry
Other: Survey only

First Posted Date: 2018-03-14

Last Posted Date: 2020-10-19

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 69

Registration Number: NCT03464383

Locations: 🇺🇸
Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States

Developing a Mobile Health Pain-Coping Skills Training Program for the Treatment of Chronic Migraine: AIM 4

Not Applicable

Withdrawn

Conditions: Chronic Migraine, Headache

Interventions: Behavioral: Treatment as Usual
Behavioral: PainCOACH Pain Coping Skills Training

First Posted Date: 2018-03-14

Last Posted Date: 2021-03-15

Lead Sponsor: Wake Forest University Health Sciences

Registration Number: NCT03465826

A Priming Intervention to Increase Patient Willingness to Use Injectables for the Management of Psoriasis

Not Applicable

Completed

Conditions: Psoriasis

Interventions: Behavioral: Group #3 (Intervention)
Behavioral: Group #2 (Intervention)

First Posted Date: 2018-03-14

Last Posted Date: 2025-04-24

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 180

Registration Number: NCT03465696

Locations: 🇺🇸
Wake Forest University Baptist Health, Winston-Salem, North Carolina, United States

Bioengineered Penile Tissue Constructs for Irreversibly Damaged Penile Corpora

Phase 1

Not yet recruiting

Conditions: Corpora Cavernosa; Inflammation
Urologic Diseases
Corpus Callosum Malformation
Trauma Injury
Male Urogenital Diseases
Penile Diseases

Interventions: Biological: Autologous tissue engineered corpora

First Posted Date: 2018-03-13

Last Posted Date: 2025-03-27

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 10

Registration Number: NCT03463239

Locations: 🇺🇸
Wake Forest Institute for Regenerative Medicine, Winston-Salem, North Carolina, United States

MucoLox Formulation to Mitigate Mucositis Symptoms in Head/Neck Cancer

Not Applicable

Terminated

Conditions: Head and Neck Cancer
Mucositis Oral

Interventions: Other: Sodium Bicarbonate
Other: MucoLox

First Posted Date: 2018-03-12

Last Posted Date: 2025-02-06

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 49

Registration Number: NCT03461354

Locations: 🇺🇸
Levine Cancer Institute, Charlotte, North Carolina, United States

Food Security and Perceptions and Barriers to Healthy Eating in Individuals With Spinal Cord Injuries

Completed

Conditions: Spinal Cord Injuries

First Posted Date: 2018-03-07

Last Posted Date: 2022-04-27

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 149

Registration Number: NCT03457558

Locations: 🇺🇸
Carolinas Rehabilitation, Charlotte, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy